Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study

Hepato-Gastroenterology

Volumn 47, Issue 35, 2000, Pages 1450-1453

  Kurtz, J E ^a   Kohser, F ^a   Negrier, S ^a   Trillet Lenoir, V ^a   Walter, S ^a   Limacher, J M ^a   Untereiner, M ^a   Kayitalire, L ^a   Jaeck, D ^a   Dufour, P ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

5 fluorouracil; Clinical benefit; Gemcitabine; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; PANCREATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0033769483     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
2. Chemotherapy prolongs survival in inoperable pancreatic cancer
3. Gemcitabin, Metabolism, Mechanisms of action and self-potentiation
4. Phase II study of gemcitabine in patients with advanced pancreatic cancer
5. Phase II trial of gemcitabine (2', 2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
6. Compassionate use of gemcitabine in advanced pancreatic cancer; A French multicentric study
7. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
8. A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma
9. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
10. Cisplatin and protracted venous infusion of 5-fluorouracil (CF): Good symptom relief with low toxicity in advanced pancreatic carcinoma
11. Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-Fluorouracil and weekly carboplatin: A Mid-Atlantic Oncology Program study
12. Biochemical modulation of folinic acid/5-fluorouracil by gemcitabine (FFG) A phase I Study
13. Reporting Results of Cancer Treatment
14. Synergistic interaction of gemcitabine and 5-fluorouracil in colon cancer cells
15. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer
16. Gemcitabine (GEM) and 5-fuorouracil (5-FU) in advanced pancreatic cancer: A GISCAD phase II study
17. Efficacite de l'association 5-fluorouracile (5-FU), acide folinique (AF) et gemcitabine (GEM) dans l'adenocarcinome pancreatique localement evolue ou metastatique (APLE/M): Resultats preliminaires
18. Phase II trial of Gemcitabine (GEM) with 24-hour infusion of 5-fluorouracil (FU) and folinic acid (FA) in patients with advanced pancreatic cancer
19. Phase I-II study of gemcitabine (GEM) and weekly 48h continuous infusion (CI) with high-dose 5-Fluorouracil (5-FU) in advanced exocrine pancreatic cancer (APC)